{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:33:46Z","timestamp":1791408826040,"version":"4.3.3"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,15]]},"DOI":"10.2169\/internalmedicine.1954-23","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T22:11:18Z","timestamp":1690323078000},"page":"833-837","source":"Crossref","is-referenced-by-count":1,"title":["Adult-onset Type II Citrullinemia Developed under Dietary Restrictions during Imprisonment"],"prefix":"10.2169","volume":"63","author":[{"given":"Takanori","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Imura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Kuno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Nojiri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Togawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Yamasaki M, Shimada T, Hamaoka S, Shibata M, Naito Y. [A case of adult-onset type II citrullinemia (CTLN2) triggered by an overseas travel]. Rinsho Shinkeigaku 54: 747-750, 2014 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.54.747"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Nakayama M, Okamoto Y, Morita T, et al. Promoting effect of citrulline in hepatocarcinogenesis: possible mechanism in hypercitrullinemia. Hepatology 11: 819-823, 1990.","DOI":"10.1002\/hep.1840110517"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kobayashi K, Sinasac DS, Iijima M, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 22: 159-163, 1999.","DOI":"10.1038\/9667"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47: 333-341, 2002.","DOI":"10.1007\/s100380200046"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ohura T, Kobayashi K, Tazawa Y, et al. Neonatal presentation of adult-onset type II citrullinemia. Hum Genet 108: 87-90, 2001.","DOI":"10.1007\/s004390000448"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Numakura C, Tamiya G, Ueki M, et al. Growth impairment in individuals with citrin deficiency. J Inherit Metab Dis 42: 501-508, 2019.","DOI":"10.1002\/jimd.12051"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Yazaki M, Ikeda S, Kobayashi K, Saheki T. [Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2): effectiveness of treatment with low-carbohydrate diet and sodium pyruvate]. Rinsho Shinkeigaku 50: 844-847, 2010 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.50.844"},{"key":"8","unstructured":"8. Shiohama N, Sugita Y, Imamura N, Sato T, Mizuno Y. [Type II citrullinemia triggered by acetaminophen]. No To Shinkei 45: 865-870, 1993 (in Japanese, Abstract in English)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Imamura Y, Kobayashi K, Shibatou T, et al. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 26: 68-72, 2003.","DOI":"10.1016\/S1386-6346(02)00331-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). Intern Med 44: 188-195, 2005.","DOI":"10.2169\/internalmedicine.44.188"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Watanabe Y, Numakura C, Tahara T, et al. Diabetes mellitus exacerbates citrin deficiency via glucose toxicity. Diabetes Res Clin Pract 164: 108159, 2020.","DOI":"10.1016\/j.diabres.2020.108159"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hayasaka K, Numakura C, Yamakawa M, et al. Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia. J Inherit Metab Dis 41: 777-784, 2018.","DOI":"10.1007\/s10545-018-0176-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ikeda S, Yazaki M, Takei Y, et al. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry 71: 663-670, 2001.","DOI":"10.1136\/jnnp.71.5.663"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hayasaka K, Numakura C, Toyota K, et al. Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia. Mol Genet Metab Rep 1: 42-50, 2014.","DOI":"10.1016\/j.ymgmr.2013.12.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cao J, An D, Galduroz M, et al. mRNA therapy improves metabolic and behavioral abnormalities in a murine model of citrin deficiency. Mol Ther 27: 1242-1251, 2019.","DOI":"10.1016\/j.ymthe.2019.04.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Akai H, Matsuda I, Kiryu S, et al. Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Eur J Radiol 81: 2973-2977, 2012.","DOI":"10.1016\/j.ejrad.2012.01.007"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_1954-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T03:31:15Z","timestamp":1710559875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_1954-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1954-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"article-number":"1954-23"}}